Skip to main content
. 2020 Aug 3;9(1):1771–1779. doi: 10.1080/22221751.2020.1799721

Figure 1.

Figure 1.

A. Trends in the resistance of Klebsiella pneumoniae to extended-spectrum β-lactam (ESBL) and carbapenem from 2008 to 2018. B. Antimicrobial resistance patterns of carbapenem-resistant Klebsiella pneumoniae (CRKP) and carbapenem-sensitive K. pneumoniae CSKP isolates in 2018. CFZ, cefazolin; CXM, cefuroxime; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; FOX, cefoxitin; ATM, aztreonam; CIP, ciprofloxacin; LEV, levofloxacin; SCF, cefoperazone/sulbactam; TZP, piperacillin/tazobactam; SXT, sulfamethoxazole/trimethoprim; AK, amikacin; GM, gentamicin; TG, tigecycline. C. Comparison of trends in carbapenem resistance in intensive care unit (ICU) and non-ICU wards from 2008–2018.